Streptomycin cell membrane finding could aid antibiotic development New study confirms streptomycin binds to receptor, which could be new target for antibiotics.…
Modified oestrogen could offer benefits of HRT without cancer risks Women who take modified oestrogen could have the benefits of hormone replacement therapy without the potential for an increased risk of breast and uterine cancer, according to the results of a study.…
Curcumin boosts immune cell power against tuberculosis Incubating cells with turmeric compound reduced Mycobacterium tuberculosis infection.…
Sperm activation finding could lead to new contraceptives Enzyme that activates sperm mobility could lead to new contraceptives or treatment for male infertility.…
Existing drugs could fight lethal viral infections Researchers say repurposed drugs, such as bupicavaine, haloperidol and fluoxetine, could treat bunyavirus infection…
Modified bleomycin reduces toxic side effects Mouse study shows deglyco-bleomycin could be less toxic alternative to standard bleomycin.…
‘Neurostatin’ prevents Alzheimer’s-related amyloid formation Roundworm study shows bexarotene could inhibit early step of amyloid-beta aggregation.…
Experimental compound mimics antidepressant effects of ketamine in mice Researchers hope CGP3466B will lead to the development of faster-acting antidepressants.…
New method to test drug-membrane interactions The development of new small molecule drugs could be accelerated using a new technique that examines how they interact on the surface of a cell.…
Researchers identify E. coli strain that protects against ‘collateral damage’ of infections A strain of Escherichia coli in the guts of mice appears to protect them from muscle wasting associated with infection and inflammatory bowel disease, according to research published in Science.…
